FTIOP
BMY.RT

Fiduciary Trust International of Pennsylvania’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Fiduciary Trust International of Pennsylvania’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$76K Buy
+19,814
New +$65.3K ﹤0.01% 349

Other funds holding BMY.RT

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Fiduciary Trust International of Pennsylvania's BMY.RT Position: Q1 2020 in Review

Fiduciary Trust International of Pennsylvania opened a new position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2020: 19,814 shares worth $76K. The stake represents ﹤0.01% of the portfolio and ranks #349 among its holdings.

581 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2020.

  • Fiduciary Trust International of Pennsylvania held 19,814 shares of Bristol-Myers Squibb Company Contingent Value Rights worth $76K as of Q1 2020.
  • Bristol-Myers Squibb Company Contingent Value Rights was a new Fiduciary Trust International of Pennsylvania position in Q1 2020.
  • Bristol-Myers Squibb Company Contingent Value Rights made up ﹤0.01% of Fiduciary Trust International of Pennsylvania's portfolio in Q1 2020, its #349 holding.
  • 581 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2020.

Based on Fiduciary Trust International of Pennsylvania's 13F filing for Q1 2020, filed 27 Apr 2020.